| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.917 | 0.002 | 0.919 | Aurora-B kinase inhibitor | 0.919 0.002 CID_10321534 0.632 0.003 CID_10028135 | CID_10321534 | |
| 0.906 | 0.002 | 0.911 | Aurora-A kinase inhibitor | 0.911 0.002 CID_10321534 0.855 0.003 CID_10028135 | CID_10321534 | |
| 0.748 | 0.004 | 0.762 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.75 0.004 CID_10321534 0.762 0.004 CID_10028135 | CID_10028135 | |
| 0.735 | 0.004 | 0.735 | c-Src kinase inhibitor | 0.724 0.004 CID_10321534 0.591 0.004 CID_10028135 | ||
| 0.722 | 0.005 | 0.722 | Antimitotic | 0.72 0.005 CID_10321534 0.694 0.005 CID_10028135 | ||
| 0.706 | 0.004 | 0.721 | Glycogen synthase kinase-3 inhibitor | 0.721 0.004 CID_10321534 0.588 0.005 CID_10028135 | CID_10321534 | |
| 0.685 | 0.004 | 0.703 | Glycogen synthase kinase-3 beta inhibitor | 0.703 0.004 CID_10321534 0.545 0.005 CID_10028135 | CID_10321534 | |
| 0.673 | 0.007 | 0.673 | Tyrosine kinase inhibitor | 0.656 0.008 CID_10321534 0.619 0.01 CID_10028135 | ||
| 0.664 | 0.005 | 0.664 | Src kinase inhibitor | 0.656 0.005 CID_10321534 0.664 0.005 CID_10028135 | ||
| 0.601 | 0.005 | 0.601 | RET inhibitor | 0.588 0.005 CID_10321534 0.421 0.009 CID_10028135 | ||
| 0.586 | 0.004 | 0.681 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.579 0.004 CID_10321534 0.681 0.004 CID_10028135 | CID_10028135 | |
| 0.586 | 0.004 | 0.68 | Abl kinase inhibitor | 0.579 0.004 CID_10321534 0.68 0.004 CID_10028135 | CID_10028135 | |
| 0.529 | 0.004 | 0.529 | Tyrosine-protein kinase receptor antagonist | 0.516 0.005 CID_10321534 0.2 0.04 CID_10028135 | ||
| 0.529 | 0.004 | 0.529 | MAP kinase kinase 2 inhibitor | 0.517 0.004 CID_10321534 0.314 0.03 CID_10028135 | ||
| 0.475 | 0.004 | 0.475 | TRKA antagonist | 0.464 0.004 CID_10321534 0.194 0.032 CID_10028135 | ||
| 0.395 | 0.013 | 0.396 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.396 0.013 CID_10321534 0.267 0.038 CID_10028135 | CID_10321534 | |
| 0.378 | 0.008 | 0.38 | LIM domain kinase 1 inhibitor | 0.38 0.008 CID_10321534 0.227 0.05 CID_10028135 | CID_10321534 | |
| 0.367 | 0.005 | 0.379 | Activin receptor-like kinase 2 inhibitor | 0.379 0.005 CID_10321534 0.185 0.044 CID_10028135 | CID_10321534 | |
| 0.374 | 0.02 | 0.374 | Growth factor antagonist | 0.337 0.023 CID_10321534 0.32 0.025 CID_10028135 | ||
| 0.431 | 0.088 | 0.431 | MAP kinase 1 inhibitor | 0.331 0.149 CID_10321534 | ||
| 0.332 | 0.004 | 0.338 | Aurora-C kinase inhibitor | 0.338 0.004 CID_10321534 0.308 0.004 CID_10028135 | CID_10321534 | |
| 0.337 | 0.014 | 0.342 | MAP-kinase-activated kinase 5 inhibitor | 0.342 0.012 CID_10321534 0.291 0.035 CID_10028135 | CID_10321534 | |
| 0.316 | 0.005 | 0.331 | Tyk2 inhibitor | 0.331 0.004 CID_10321534 0.229 0.006 CID_10028135 | CID_10321534 | |
| 0.312 | 0.004 | 0.312 | Insulin growth factor antagonist | 0.273 0.005 CID_10321534 0.126 0.03 CID_10028135 | ||
| 0.321 | 0.016 | 0.321 | Protein-tyrosine kinase Lyn inhibitor | 0.314 0.017 CID_10321534 0.27 0.025 CID_10028135 | ||
| 0.308 | 0.004 | 0.308 | Insulin like growth factor 1 antagonist | 0.27 0.005 CID_10321534 0.121 0.029 CID_10028135 | ||
| 0.316 | 0.022 | 0.316 | TRKC antagonist | 0.307 0.025 CID_10321534 0.209 0.063 CID_10028135 | ||
| 0.283 | 0.004 | 0.283 | Bcr-Abl kinase inhibitor | 0.189 0.011 CID_10321534 0.112 0.031 CID_10028135 | ||
| 0.263 | 0.007 | 0.267 | Janus tyrosine kinase 2 inhibitor | 0.267 0.007 CID_10321534 0.162 0.018 CID_10028135 | CID_10321534 | |
| 0.276 | 0.022 | 0.29 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.275 0.023 CID_10321534 0.29 0.019 CID_10028135 | CID_10028135 | |
| 0.26 | 0.015 | 0.26 | TRKB antagonist | 0.25 0.017 CID_10321534 0.146 0.05 CID_10028135 | ||
| 0.251 | 0.037 | 0.253 | I kappa B kinase epsilon inhibitor | 0.253 0.036 CID_10321534 | CID_10321534 | |
| 0.219 | 0.009 | 0.229 | Janus tyrosine kinase 3 inhibitor | 0.229 0.009 CID_10321534 0.121 0.026 CID_10028135 | CID_10321534 | |
| 0.205 | 0.014 | 0.205 | Insulin receptor antagonist | 0.144 0.029 CID_10321534 | ||
| 0.287 | 0.1 | 0.287 | Angiogenesis inhibitor | 0.259 0.117 CID_10321534 0.233 0.136 CID_10028135 | ||
| 0.207 | 0.036 | 0.25 | Cyclin-dependent kinase inhibitor | 0.25 0.027 CID_10321534 0.103 0.087 CID_10028135 | CID_10321534 | |
| 0.181 | 0.013 | 0.181 | Leucine-rich repeat kinase 2 inhibitor | 0.156 0.018 CID_10321534 | ||
| 0.184 | 0.02 | 0.184 | Polo-like kinase-4 inhibitor | 0.17 0.025 CID_10321534 0.11 0.066 CID_10028135 | ||
| 0.168 | 0.014 | 0.168 | ErbB-3 antagonist | 0.141 0.021 CID_10321534 0.119 0.03 CID_10028135 | ||
| 0.19 | 0.038 | 0.21 | Cyclin-dependent kinase 7 inhibitor | 0.21 0.03 CID_10321534 0.129 0.077 CID_10028135 | CID_10321534 | |
| 0.195 | 0.043 | 0.195 | Lck kinase inhibitor | 0.191 0.045 CID_10321534 0.132 0.077 CID_10028135 | ||
| 0.191 | 0.041 | 0.191 | Vascular endothelial growth factor antagonist | 0.169 0.048 CID_10321534 0.143 0.057 CID_10028135 | ||
| 0.182 | 0.04 | 0.182 | Vascular endothelial growth factor 2 antagonist | 0.158 0.047 CID_10321534 0.119 0.061 CID_10028135 | ||
| 0.163 | 0.022 | 0.172 | CDK2/cyclin A inhibitor | 0.172 0.019 CID_10321534 0.115 0.046 CID_10028135 | CID_10321534 | |
| 0.199 | 0.075 | 0.231 | Death-associated protein kinase 3 inhibitor | 0.231 0.06 CID_10321534 0.144 0.132 CID_10028135 | CID_10321534 | |
| 0.158 | 0.034 | 0.185 | Cyclin-dependent kinase 2 inhibitor | 0.185 0.028 CID_10321534 0.094 0.077 CID_10028135 | CID_10321534 | |
| 0.142 | 0.018 | 0.17 | CDK2/cyclin E2 inhibitor | 0.17 0.014 CID_10321534 0.084 0.036 CID_10028135 | CID_10321534 | |
| 0.14 | 0.017 | 0.14 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.133 0.019 CID_10321534 0.093 0.04 CID_10028135 | ||
| 0.163 | 0.043 | 0.169 | MAP3K9 inhibitor | 0.169 0.036 CID_10321534 0.137 0.082 CID_10028135 | CID_10321534 | |
| 0.137 | 0.024 | 0.137 | ErbB-4 antagonist | 0.102 0.039 CID_10321534 0.071 0.059 CID_10028135 | ||
| 0.137 | 0.034 | 0.158 | CDK/cyclin complex inhibitor | 0.158 0.027 CID_10321534 | CID_10321534 | |
| 0.135 | 0.037 | 0.19 | Fibroblast growth factor 1 antagonist | 0.112 0.048 CID_10321534 0.19 0.019 CID_10028135 | CID_10028135 | |
| 0.171 | 0.08 | 0.189 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.189 0.071 CID_10321534 | CID_10321534 | |
| 0.109 | 0.022 | 0.109 | Cyclin A2 inhibitor | 0.108 0.022 CID_10321534 | ||
| 0.104 | 0.022 | 0.104 | Cyclin A inhibitor | 0.104 0.022 CID_10321534 | ||
| 0.149 | 0.067 | 0.157 | Vascular endothelial growth factor 3 antagonist | 0.157 0.061 CID_10321534 | CID_10321534 | |
| 0.103 | 0.023 | 0.116 | Cyclin E inhibitor | 0.116 0.019 CID_10321534 0.05 0.048 CID_10028135 | CID_10321534 | |
| 0.12 | 0.046 | 0.14 | Cyclin-dependent kinase 9 inhibitor | 0.14 0.037 CID_10321534 | CID_10321534 | |
| 0.104 | 0.03 | 0.104 | Fibroblast growth factor 3 antagonist | 0.084 0.046 CID_10321534 | ||
| 0.111 | 0.038 | 0.125 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.125 0.032 CID_10321534 | CID_10321534 | |
| 0.156 | 0.084 | 0.156 | Cyclin-dependent kinase 3 inhibitor | 0.145 0.11 CID_10321534 | ||
| 0.087 | 0.022 | 0.104 | Cyclin E1 inhibitor | 0.104 0.018 CID_10321534 | CID_10321534 | |
| 0.071 | 0.007 | 0.074 | Purinergic P2T antagonist | 0.074 0.007 CID_10321534 0.03 0.012 CID_10028135 | CID_10321534 | |
| 0.083 | 0.024 | 0.093 | Tyrosine-protein kinase EMT inhibitor | 0.093 0.02 CID_10321534 | CID_10321534 | |
| 0.166 | 0.114 | 0.166 | EphB2 antagonist | 0.141 0.139 CID_10321534 | ||
| 0.102 | 0.052 | 0.11 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.11 0.046 CID_10321534 0.077 0.075 CID_10028135 | CID_10321534 | |
| 0.137 | 0.087 | 0.137 | Heat shock protein 70 antagonist | |||
| 0.114 | 0.064 | 0.123 | CDK3/cyclin E inhibitor | 0.123 0.051 CID_10321534 | CID_10321534 | |
| 0.082 | 0.034 | 0.106 | Cyclin-dependent kinase 4 inhibitor | 0.106 0.024 CID_10321534 | CID_10321534 | |
| 0.106 | 0.059 | 0.122 | Platelet activating factor beta antagonist | 0.081 0.078 CID_10321534 0.122 0.049 CID_10028135 | CID_10028135 | |
| 0.098 | 0.053 | 0.098 | Protein kinase C zeta inhibitor | 0.09 0.065 CID_10321534 | ||
| 0.083 | 0.038 | 0.083 | Syk tyrosine kinase inhibitor | 0.075 0.044 CID_10321534 | ||
| 0.071 | 0.03 | 0.073 | Cyclin-dependent kinase 6 inhibitor | 0.073 0.028 CID_10321534 | CID_10321534 | |
| 0.089 | 0.049 | 0.089 | ALK inhibitor | 0.087 0.051 CID_10321534 | ||
| 0.148 | 0.11 | 0.16 | Death-associated protein kinase 2 inhibitor | 0.16 0.085 CID_10321534 | CID_10321534 | |
| 0.123 | 0.087 | 0.137 | Ribosomal protein S6 kinase inhibitor | 0.137 0.075 CID_10321534 | CID_10321534 | |
| 0.1 | 0.066 | 0.162 | Vascular endothelial growth factor 1 antagonist | 0.083 0.081 CID_10321534 0.162 0.037 CID_10028135 | CID_10028135 | |
| 0.116 | 0.087 | 0.155 | Glycogen synthase kinase-3 alpha inhibitor | 0.155 0.063 CID_10321534 | CID_10321534 | |
| 0.27 | 0.245 | 0.27 | Antiinflammatory | |||
| 0.124 | 0.1 | 0.139 | Death-associated protein kinase 1 inhibitor | 0.139 0.06 CID_10321534 | CID_10321534 | |
| 0.098 | 0.078 | 0.098 | EphA2 antagonist | |||
| 0.068 | 0.049 | 0.08 | CDK1/cyclin B1 inhibitor | 0.08 0.039 CID_10321534 | CID_10321534 | |
| 0.088 | 0.07 | 0.117 | Protein kinase C mu inhibitor | 0.117 0.044 CID_10321534 | CID_10321534 | |
| 0.087 | 0.077 | 0.106 | Cyclin-dependent kinase 1 inhibitor | 0.106 0.063 CID_10321534 | CID_10321534 | |
| 0.023 | 0.016 | 0.023 | Purinergic P2Y12 antagonist | 0.021 0.018 CID_10321534 | ||
| 0.081 | 0.074 | 0.081 | Hepatocyte growth factor antagonist | |||
| 0.067 | 0.065 | 0.099 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.099 0.036 CID_10321534 | CID_10321534 | |
| 0.049 | 0.047 | 0.052 | Janus tyrosine kinase 1 inhibitor | 0.052 0.045 CID_10321534 | CID_10321534 | |
| 0.06 | 0.059 | 0.089 | Check point kinase 1 inhibitor | 0.089 0.033 CID_10321534 | CID_10321534 | |
| 0.07 | 0.078 | 0.086 | I kappa B kinase inhibitor | 0.086 0.052 CID_10321534 | CID_10321534 | |
| 0.05 | 0.062 | 0.058 | Cyclin A1 inhibitor | 0.058 0.043 CID_10321534 | CID_10321534 | |
| 0.075 | 0.094 | 0.18 | Ephrin antagonist | 0.18 0.03 CID_10028135 | CID_10028135 | |
| 0.072 | 0.094 | 0.09 | Protein kinase (CK2) inhibitor | 0.09 0.072 CID_10321534 | CID_10321534 | |
| 0.182 | 0.223 | 0.192 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.192 0.19 CID_10321534 | CID_10321534 | |
| 0.067 | 0.12 | 0.101 | Granulocyte macrophage colony stimulating factor antagonist | 0.101 0.07 CID_10028135 | CID_10028135 | |
| 0.095 | 0.181 | 0.273 | Polo-like kinase-3 inhibitor | 0.273 0.017 CID_10028135 | CID_10028135 | |
| 0.059 | 0.156 | 0.086 | Polo-like kinase-1 inhibitor | 0.086 0.071 CID_10028135 | CID_10028135 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |